AbbVie Stock Inching Toward Highs Amid Drug Sale Talks

Citigroup raised its price target to $125 from $105

Deputy Editor
Mar 16, 2021 at 10:19 AM
facebook twitter linkedin

AbbVie Inc (NYSE:ABBV) is in the spotlight this morning, after news that the pharmaceutical company is in talks to sell a $5 billion portfolio of women's drugs. According to Reuters, the company acquired these drugs through its $63 billion purchase of Allergan this past year. Furthermore, Citigroup today raised its price target on the equity to $125 from $105. At last check, ABBV was up 0.5% to trade at $110.76.

On the charts, ABBV has been creeping up toward its recent Jan. 13 nearly three-year high of $113.41. A double layer of support looks to have formed at both the $102 level and 80-day moving average. Year-over-year, the equity is up 49%. 

Analysts are mostly bullish on AbbVie stock, with 12 of the 16 analysts in coverage at a "buy" or better rating. Plus, the 12-month consensus price target of $122.63 comes into today with a 10.8% premium to current levels. 

Sentiment is similar in the options pits. ABBV's 50-day call/put volume ratio of 3.69 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) stands higher than 91% of readings from the past year. This means long calls have been picked up at a much faster-than-usual rate over the last 10 weeks. 

Now might not be a bad time to weigh in on these options either. The stock's Schaeffer's Volatility Index (SVI) of 25% stands higher than just 9% of all other readings in its annual range, implying that options players are pricing in relatively low volatility expectations at the moment. 


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners